Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.
Recursion Pharma is a Salt Lake City-based drug discovery company founded in 2013 based on technology developed at the University of Utah. Recursion uses a novel drug screening platform to efficiently reposition known drugs and shelved pharmaceutical assets to treat rare genetic diseases and other conditions.
- Chris Gibson, PhD
- Blake Borgeson, PhD
- Dean Li, PhD
- Our Business & Administration teams are hiring! Learn more about our open positions at https://t.co/aqOm6IXQEm https://t.co/CL5fsJsyYE
- In last week's blog, we shared how we can speed up science by increasing the precision of in vivo studies to minimi… https://t.co/68hnozuLKC
- Our Business & Administration teams are hiring! Learn more about our open positions at https://t.co/aqOm6Jfs2W https://t.co/N6OHPSP6jx